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Abstract 
Background: The glucosyltransferase UGT76G1 from Stevia rebaudiana is a chameleon enzyme in the targeted 
biosynthesis of the next-generation premium stevia sweeteners, rebaudioside D (Reb D) and rebaudioside M (Reb M). 
These steviol glucosides carry five and six glucose units, respectively, and have low sweetness thresholds, high maxi-
mum sweet intensities and exhibit a greatly reduced lingering bitter taste compared to stevioside and rebaudioside A, 
the most abundant steviol glucosides in the leaves of Stevia rebaudiana.
Results: In the metabolic glycosylation grid leading to production of Reb D and Reb M, UGT76G1 was found to 
catalyze eight different reactions all involving 1,3-glucosylation of steviol C13- and C19-bound glucoses. Four of these 
reactions lead to Reb D and Reb M while the other four result in formation of side-products unwanted for production. 
In this work, side-product formation was reduced by targeted optimization of UGT76G1 towards 1,3 glucosylation of 
steviol glucosides that are already 1,2-diglucosylated. The optimization of UGT76G1 was based on homology model-
ling, which enabled identification of key target amino acids present in the substrate-binding pocket. These residues 
were then subjected to site-saturation mutagenesis and a mutant library containing a total of 1748 UGT76G1 variants 
was screened for increased accumulation of Reb D or M, as well as for decreased accumulation of side-products. This 
screen was performed in a Saccharomyces cerevisiae strain expressing all enzymes in the rebaudioside biosynthesis 
pathway except for UGT76G1.
Conclusions: Screening of the mutant library identified mutations with positive impact on the accumulation of 
Reb D and Reb M. The effect of the introduced mutations on other reactions in the metabolic grid was characterized. 
This screen made it possible to identify variants, such as UGT76G1Thr146Gly and UGT76G1His155Leu, which diminished 
accumulation of unwanted side-products and gave increased specific accumulation of the desired Reb D or Reb M 
sweeteners. This improvement in a key enzyme of the Stevia sweetener biosynthesis pathway represents a significant 
step towards the commercial production of next-generation stevia sweeteners.
© The Author(s) 2016. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
The metabolic syndrome, which has become so preva-
lent in the industrialized countries throughout the world 
is associated with abdominal obesity, increased risks of 
developing cardiovascular diseases, and type 2 diabetes. 
This syndrome may be tracked back to our human ances-
tors who to meet their energy demand were dependent 
on carbohydrate rich cereals and ripe fruits that were 
recognized by their sweet taste. This innate attraction to 
sweet taste has become a severe health issue when food is 
plentiful and the diet’s calorie intake of sucrose and fruc-
tose syrups becomes excessive [1, 2].
To reduce the contribution of sucrose and other high-
energy sweeteners to excessive human calorie intake, 
especially in the industrialized part of the world, chemi-
cally synthesized low- and zero-calorie sweeteners like 
saccharin and aspartame have been introduced, which 
90% of American adults are using at least once every 
2  weeks [3]. These have organoleptic drawbacks com-
pared to sucrose and fructose syrups, and consumer 
demand for natural non-caloric sweeteners instead of 
chemically synthesized artificial sweeteners spurred a 
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search for natural and generally healthy non-nutritive 
sweeteners. Steviol glucosides from the leaves of Stevia 
rebaudiana constitute such a natural alternative [4].
Leaves of the “sweet herb” Stevia rebaudiana contain 
a mix of steviol glycosides and have been used as natu-
ral sweeteners in South America for centuries. The safety 
of the steviol glucosides has been ascertained by stud-
ies of their catabolism and their use as food additives 
resulting in their general use in the US as well as in the 
EU [4–9]. Steviol glucosides consist of a diterpenoid ste-
viol backbone decorated with one to three glucoses at the 
steviol C13-hydroxyl and/or C19-carboxylic acid positions 
(Fig.  1). The C16-C17 methylene double bond present in 
the natural steviol glycosides is a pharmacophore essen-
tial for the sweetness properties of this class of molecules 
[10]. The maximum sweetness perceived correlates posi-
tively to the total number of glucose residues present 
whereas the substitution of a β-1,2-glucose with an α-1,2-
rhamnose, greatly reduces sweetness [11]. The lingering 
bitter off-flavor of some steviol glycosides is related to 
their binding to human bitter taste receptors belonging 
to the class of hTAS2R type receptors whereas sweet taste 
sensations are mediated by G-protein coupled receptors 
like heteromers of hTAS1R2 and hTAS1R3 situated in 
the taste buds [11]. It is the sweet threshold concentra-
tion compared to the bitter threshold concentration that 
determines how steviol glycosides are perceived when 
consumed as part of a diet.
More than 35 different steviol glycosides have been 
identified in S. rebaudiana [5, 12]. In S. rebaudiana, 
the glucosylation reactions are catalyzed by the action 
of four UDPG-dependent glucosyltransferases (UGTs): 
UGT85C2 glucosylates the steviol backbone at the C13-
hydroxyl position forming a β-d-glucoside whereas 
UGT74G1 glucosylates the C19-carboxylic acid functional 
group giving rise to the formation of an ester (Fig.  1) 
[13]. UGT91D2 and UGT76G1 catalyze glucosylation of 
the two glucose moieties directly bound to the C13- and 
C19-positions via formation of 1,2-β-d- and 1,3-β-d-
glucosidic linkages, respectively. While UGT76G1 is 
capable of catalyzing 1,3-β-d-glucosylations on both 
mono- and 1,2-disaccharides attached to the steviol C13 
and C19-positions, UGT91D2 has not been shown to cat-
alyze 1,2-β-d-glucosylation if a 1,3-disaccharide is already 
present on the C13- or C19-position, potentially yielding a 
number of 1,3-glucosylated side-products [13–16].
The most abundant steviol glucosides in S. rebaudiana 
are the tri-glucosylated 1,2-stevioside, the tetra-gluco-
sylated rebaudioside A (Reb A) and the tetra-glycosylated 
rebaudioside C (Reb C) constituting 5–10, 2–4 and 1–2% 
of the leaf dry weight, respectively [17]. The 1,2-ste-
vioside and Reb A are 250–300 times more sweet than 
sucrose but possesses a bitter lingering aftertaste [7, 18]. 
Reb C is only 30 times sweeter than glucose as a result 
of the attachment of a rhamnose moiety to the glu-
cose moiety at the C13 position [19]. The less abundant 
Fig. 1 Steviol and the metabolic grid of glucosylation reactions resulting in formation of Reb D and Reb M. Top left the structure of steviol with 
emphasis on its functional groups. Reb D and Reb M are the two desired sweeteners (shown on green background). UGT91D2 has not been 
observed to glucosylate glucoside structures that harbor a glucose residue bound in a 1,3-glucosidic linkage. Formation of the 1,3-bond prior to for-
mation of the 1,2-bond results in production of undesired side-products (shown on red background) [13, 15, 16]. UGT76G1 is known to glucosylate 
Steviol-13-O-monoglucoside (13-SMG), rubusoside, 1,2-stevioside and Reb D. In this study, 1,2-bioside, Reb G, Reb A and Reb E were identified as 
additional UGT76G1 substrates. UGT76G1 catalyzed glucosylation of Reb G and Reb A lead to the formation and structural elucidation of two new 
steviol glucosides Reb Q and Reb I
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penta-glucoside Rebaudioside D (Reb D) and hexa-gluco-
side Rebaudioside M (Reb M) and blends thereof have a 
sweetness potency up to 350 times that of sucrose while 
having a greatly reduced lingering bitterness [7]. Taste 
tests at high concentrations registered Reb D among the 
sweetest and as significantly less bitter than Reb B [20]. 
Reb M is characterized by a high sweetness intensity, 
a fast sweetness on-set, a clean taste and with greatly 
reduced licorice, bitter, sour and astringent aftertaste in 
comparison to Reb A and other steviol glucosides [7]. 
These properties render Reb D and Reb M superior tar-
gets as high potency natural sweeteners. Reb D and Reb 
M are only present in the leaves of S. rebaudiana in min-
ute quantities (approx. 0.4–0.5% w/w total dry weight) 
making it impractical and costly to purify these two com-
pounds from the stevia plant for industrial use [7, 21]. As 
the genes encoding biosynthesis of the steviol glucosides 
including Reb D and Reb M have been identified, heter-
ologous production of Reb D and Reb M in microorgan-
isms offers an attractive sustainable alternative. With this 
aim, the steviol glucoside pathway has been successfully 
expressed in the yeast S. cerevisiae [16]. Two advantages 
of microbial factories are the ability to control the lev-
els of expression of the different pathway genes and the 
inherent opportunity to use mutational studies to modify 
the substrate specificity of the enzymes involved.
In the current study, UGT76G1 was mutagenized to 
improve a S. cerevisiae stevia production host for desired 
combinations of steviol glucosides with a special focus 
on Reb D and Reb M due to their superior sweetness and 
organoleptic properties. The challenge faced is that Reb 
D and Reb M are not formed in a linear pathway from 
steviol, but are formed as products in a metabolic gly-
cosylation grid and their formation is directly depend-
ent on the catalytic activity of UGT76G1 to convert 
1,2-stevioside to Reb A, and Reb D to Reb M. However, 
UGT76G1 acts like a chameleon enzyme in the pathway, 
catalyzing different reactions in the metabolic glycosyla-
tion grid (Fig.  1). It is known to catalyze the additional 
conversion of steviol-C13-glucoside (13-SMG) and rubu-
soside into 1,3-bioside and 1,3-stevioside (Rebaudioside 
G), respectively [16]. Formation of these side-products 
could diminish the final accumulation of Reb D and Reb 
M in the production strain (Fig. 1). Increased production 
of Reb D and Reb M would thus require optimization 
of UGT76G1 catalytic activity towards glucosylation of 
1,2-stevioside, Reb E and Reb D, the substrates for forma-
tion of Reb D and Reb M, respectively.
The substrate specificity of UGT76G1 was defined in 
detail by assaying for activity towards four additional 
steviol glucosides in  vitro. Homology modelling of 
UGT76G1 was used to predict which residues are likely 
to contribute to the formation of the binding pocket and 
the active site. A site-saturation mutation library for each 
of the selected residues was generated to optimize the 
geometry of the binding pocket and favor the produc-
tion of Reb D and Reb M. In this way, 1748 UGT76G1 
variants were generated and expressed in S. cerevisiae. 
This resulted in identification of UGT76G1 variants with 
reduced ability to catalyze the formation of side-prod-
ucts and increased formation of Reb D and Reb M in S. 
cerevisiae.
Methods
In vitro characterization of UGT76G1 reactions
Using the lithium acetate transformation protocol [22], 
p416-GPD [23] and p416-GPD harboring UGT76G1 
were used to transform the protease deficient yeast strain 
DSY-6 (MATa leu2 trp1delta63 ura3-52 prb1-22 pep4-3 
prc1-407, Dualsystems Biotech, Schlieren, Switzerland). 
Transformants were selected on plates containing Syn-
thetic Complete media without uracil (SC-ura). Three 
clones were grown in 1 ml SC-ura media in 96 deep well 
plates (Ratiolab, Dreieich, Germany) and incubated for 
2 days at 30 °C and 400 rpm in an orbital shaker. Aliquots 
(100 µl) from each culture were subsequently diluted in 
1 ml of fresh SC-ura media and incubated for 1 day. To 
obtain a cell lysate containing UGT76G1, the cultures 
were centrifuged (3220g/20  min) and the pellets lysed 
with CelLytic™ Y cell lysis reagent (Sigma-Aldrich, St. 
Louis, Missouri, USA) according to manufacturer’s rec-
ommendation. The lysates (6 µl aliquots) were added to 
a reaction mixture (total volume of 30  µl) consisting of 
0.1 M Tris(hydroxymethyl)aminomethane (Tris, pH 8.0), 
0.3 mM UDPG (Sigma-Aldrich, St. Louis, MO, USA) and 
0.1 mM of either of the following substrates: 1,2-bioside; 
rubusoside; 1,2-stevioside; rebaudioside E; rebaudioside 
A and rebaudioside D (LGC Standards, Wesel, Germany). 
Samples for time-course experiments were taken after 
0, 1, 2 and 18 h. Reactions were stopped by adding 25 µl 
dimethyl sulfoxide (DMSO) to a 25 µl aliquot of the reac-
tion mixture.
Steviol glycoside analysis by LC–MS
Liquid chromatography mass spectrometry (LC–MS) 
analyses were performed using an Ultimate 3000-RS 
UPLC (Dionex Thermo Fisher Scientific) equipped with a 
Waters Acquity UPLC ®BEH C18 column (2.1 × 50 mm, 
1.7  µm particles, 130  Å pore size, flow rate: 0.4  ml/
min, column temperature of 35  °C) coupled to a Quan-
tum Access TSQ triple quadrupole mass spectrometer 
(Thermo Fisher Scientific) with electrospray ionization 
(ESI) operated in positive mode. The mobile phases were: 
A, H2O with 0.1% formic acid (HCOOH) and B, acetoni-
trile (CH3CN) with 0.1% HCOOH. The gradient used 
was: 0.0–4.0 min linear gradient 25–47% B; 4.0–5.0 min, 
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linear increase 47–100% B; 5.0–5.5  min, 100% B; re-
equilibrate to the gradient starting ratio). The masses 
corresponding to Steviol-C13- and -C19-glucosides (13- 
and 19-SMG; m/z 481.3 [M+H]+ and 503.3 [M+Na]+), 
Steviol  +  2 glucoses (Rubusoside, 1,2- and 1,3-bioside; 
m/z 665.3 [M+Na]+), Steviol  +  3 glucoses (1,2-stevio-
side, Reb B and G;  m/z 827.4 [M+Na]+), Steviol + 4 glu-
coses (Reb A, E and Q;  m/z 989.4 [M+Na]+), Steviol + 5 
glucoses (Reb D and I;  m/z 1151.5 [M+Na]+) and Ste-
viol +  6 glucoses (Reb M;  m/z 1313.5 [M+Na]+) were 
monitored using single ion monitoring (SIM) and quan-
tified by comparison with authentic standards, when 
available.
Homology modeling of UGT76G1 and docking of steviol 
glucosides
Homology modelling of UGT76G1 was performed using 
the ORCHESTRA module in Sybyl-X 2.0 (Certara, St. 
Louis MO) using the following PDB-files as templates: 
2PQ6, 2C1X, 3HBF and 2VCE. The ligands in PDB:2VCE 
were used during the generation of the main- and side-
chains and removed prior to energy minimization with 
an AMBER FF99 force field. Model geometry and qual-
ity were checked with the web servers molprobity [24, 25] 
and ProQ [26]. The uridine diphosphate glucose (UDPG) 
fluorinated-sugar donor analog UDP-2-deoxo-2-fluoro 
glucose (UDP-2FGlc) from PDB: 2VCE was imported 
into the UDPG binding site of UGT76G1 prior to the ste-
viol glucoside acceptor substrates. Models of Reb D and 
Reb M were prepared using the SybylX small molecule 
builder and docked into the active site of the enzyme with 
the Surflex-Dock GeomX module allowing for protein 
flexibility. The sites targeted for site-saturation mutagen-
esis were determined by selecting residues within a 5 Å 
distance of Reb D and Reb M in the docking analysis with 
exclusion of residues that were found to be 100% con-
served in the PDB-templates.
Design of the UGT76G1 site‑saturation library vectors
For each of the selected amino acids in the active site to 
be mutagenized, a site-saturation library was generated 
by BaseClear (Leiden, The Netherlands). A total of 38 
UGT76G1 libraries were generated by PCR using NNS-
degenerate primers, with N designating that A, C, G, or T 
nucleotides are present in the first two codon positions, 
and S designating the presence of G or C nucleotides in 
the third codon position for the position to be site-sat-
urated. The mutagenized constructs were then cloned 
into p416-GPD using the restriction sites SpeI and XhoI. 
The quality of the libraries was assessed by sequencing 
96 colonies for each of two libraries to verify the pres-
ence of  >17 variants in the library pool. In addition, 
2–3 colonies of each of the remaining 36 libraries were 
sequenced to ensure the presence of variants at the 
desired positions.
Determination of the in vivo activity of UGT76G1 
site‑saturation library in steviol glucoside producing S. 
cerevisiae strain
Using the lithium acetate protocol [22], the 38 UGT76G1 
site-saturation libraries were transformed into a S. cerevi-
siae strain harboring all the genes required for Reb M bio-
synthesis except UGT76G1 [16]. Forty-six transformants 
and two wild-type UGT76G1 controls for each library 
site were inoculated in 1  ml SC-ura and grown for 4 d 
(400 rpm orbital shaking, 30 °C). Aliquots (50 µl) of cells 
from each culture were added to 50  µl DMSO, heated 
at 80  °C for 10  min, and centrifuged (3220g/10  min) to 
obtain a clear supernatant. LC–MS was used to ana-
lyze the extracts for their content of Reb D and Reb M 
as described above. The Genejet Plasmid Miniprep Kit 
(Thermo Fisher Scientific, Waltham, Massachusetts, 
USA) was used to purify plasmids from yeast colonies 
expressing UGT76G1 variants of interest. The procedure 
was performed according to manufacturer’s recommen-
dations except for the introduction of a bead-bashing step 
to break the cells after the addition of the resuspension 
buffer. Glass beads [one-third (v/v), 425–600 µm, Sigma] 
were added to the resuspended cultures which were then 
treated for 20 s at max speed in a Thermo Electron Fast-
Prep FP120 Cell Disruptor (Thermo Fisher Scientific, 
Waltham, Massachusetts, USA). Selected UGT76G1 var-
iants were sequenced by Macrogen Europe, (Amsterdam, 
The Netherlands) and the plasmids were re-transformed 
into the S. cerevisiae producing strain lacking UGT76G1 
and incubated as described above in triplicate to elimi-
nate the possibility of phenotypes observed due to 
genetic background changes. Accumulation of the steviol 
glucosides presented in Fig. 1 was monitored by LC–MS 
as described above.
Results
In vitro characterization of UGT76G1’s activity on steviol 
glucosides
To identify all potential UGT76G1 substrates, the sub-
strate specificity of wild-type UGT76G1 obtained as a 
DSY-6 lysate was tested in in vitro assays in the presence 
of steviol glucosides and UDPG. The time course experi-
ments (Fig.  2) demonstrated that, besides glucosylating 
13-SMG (not tested in this study), 1,2-bioside 1,2-stevio-
side and Reb D, the enzyme was capable of glucosylating 
rubusoside, Reb E, Reb G and Reb A, catalyzing 1,3-glu-
cosylations at the C13- as well as C19-positioned glucose 
moieties on the steviol backbone (Fig. 1).
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Based on percentage changes in area under the curve 
(AUC) values, the results demonstrate that UGT76G1 
was much more efficient at catalyzing 1,3-glucosylations 
of the glucose moiety linked directly to the C13-position 
of the steviol ring system in comparison to glucose moi-
eties located at the C19-position. This was manifested in 
the almost complete glucosylation of 1,2-bioside, 1,2-ste-
vioside and Reb E within an 18  h period with the best 
substrate for glucosylation at the C19 position being Reb 
D (Fig. 2).
Identification of novel steviol glucoside side‑products
LC–MS analysis on reaction mixtures containing cell 
lysate from S. cerevisiae expressing wild-type UGT76G1 
and added rubusoside or Reb G revealed the produc-
tion of a novel compound with a mass corresponding to 
a steviol tetra-glucoside, while incubation with 1,2-ste-
vioside and Reb A gave rise to a compound correspond-
ing to a novel steviol penta-glucoside. Since UGT76G1 
has only been shown to catalyze 1,3-glucosylations, the 
tetra-glucoside is expected to be a steviol glucoside with 
Fig. 2 1.3-Glucosylation reactions catalyzed by wild-type UGT76G1. Substrates tested were: a rubusoside, b 1,2-bioside, c 1,2-stevioside, d Reb A, e 
Reb D and f Reb E. Each substrate was administered at an initial concentration of 0.1 mM. Substrate conversion and formation of 1,3-mono-, di- and 
tri-glucosylated products are shown in blue, red and green traces, respectively. Reb I resulting from glucosylation of Reb A is not depicted due to 
partial co-elution with Reb A and 1,2-stevioside which prevents integration of the Reb I peak in the LC-MS results. The AUC units depicted do not 
offer the ability to make quantitative comparisons between different components
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an attached 1,3-glucose moiety positioned at both the 
C13- and C19-glucoses. We named this novel compound 
rebaudioside Q (Reb Q, Fig. 1). In a similar manner, the 
penta-glucoside is expected to be rebaudioside I (Reb I, 
Fig. 1, [12, 27]). In our experimental setup, Reb I partly 
co-elute with 1,2-stevioside and Reb A preventing deter-
mination of a specific AUC for this compound (Addi-
tional file 1: Figure S1).
In silico analysis
Homology modelling of UGT76G1 was performed based 
on the crystal structures for the plant UGTs with the 
highest sequence identity (ID). These were MtUGT85H2 
(PDB: 2PQ6, ID  =  30.5%), VvGT1 (PDB: 2C1X, 
ID = 29.4%), MtUGT78G1 (PDB: 3HBF; ID = 27.0%) and 
AtUGT72B1 (PBD: 2VCE, ID = 27.3%) [28–31] (Fig. 3).
UGT76G1 folded into the expected two Rossmann 
fold domain structure characteristic of GT-B folded Lel-
oir (nucleotide-dependent) glycosyl transferases [32–34] 
with Ile15-Glu236 constituting the N-terminal aglycon 
acceptor domain and Ser255-Val456 constituting the 
C-terminal UDPG-donor domain connected by the linker 
Ile237-Ser254. The quality of the UGT76G1 homol-
ogy modelling was evaluated by calculating Molprobity 
score, LGscore and MaxSub values with the webservers 
Molprobity and ProQ [24–26]. The Molprobity score was 
1.89, LG score 5.761 and the MaxSub value 0.201. These 
values all indicate a high probability of correct folding 
and thus high quality of the obtained UGT76G1 model.
Superimposition of UGT76G1 with the four crystal 
based templates showed that the tertiary structure of 
the C-terminal domain was highly conserved between 
UGT76G1 and the templates, reflecting its major func-
tion as the UDPG binding domain. The N-terminal 
domain, responsible for binding the glucose-accep-
tor substrates, was more variable with several regions 
that deviated more than 4  Å between their respec-
tive Cα-atoms. These differences were described to the 
vast structural differences in sugar-acceptor substrates 
(Fig. 4).
The high structural identity between the C-termi-
nal domain of UGT76G1 and the four crystal based 
Fig. 3 UGT76G1 homology model with Reb M (cyan) and the UDPG fluoride analog UDP-2FGlc (magenta) docked in the active site. The model 
shows the parallel β-sheets (yellow arrows) and the α-helices (red) of the two Rossmann folds making up the N- and C-terminal domains characteris-
tic of family 1 UGTs
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structures and the known conformation of the sugar 
donor in the crystal based structures enabled docking of 
the catalytically inactive fluorinated UDPG-analog UDP-
2FGlc from the crystal structure of UGT72B1 (PDB: 
2VCE; Shao et al. [35]) into UGT76G1. This constrained 
the available space in the binding pocket before introduc-
tion of the steviol glucosides. Forty-nine amino acid resi-
dues in the binding pocket were considered relevant for 
Reb D and Reb M binding and activity. Eleven of these 
residues were omitted from the site-saturation library 
screen because these amino acids were found to be fully 
conserved within UGT76G1 and all four templates used 
and therefore expected to be important for catalytic 
function. These conserved residues include His25 and 
Asp124, the two amino acids presumed to be responsible 
for transferring the sugar moiety from the donor UDPG 
molecule to the acceptor substrate [28–31] and Trp338-
Gln381 which are part of the highly conserved plant 
secondary product glycosyltransferase (PSPG)-motif 
responsible for UDPG binding [36]. Finally, Pro21 is 
expected to stabilize a loop prior to the α-helix contain-
ing the catalytic His25, while Phe281, Gly282 and Arg311 
form part of the hydrophobic core in the C-terminal 
domain. The remaining 38 amino acid sites were targeted 
for site-saturation mutagenesis (Fig. 4).
In vivo site‑saturation mutagenesis screen
The 38 residues selected from the in silico analysis were 
individually mutagenized with NNS-primers and trans-
formed into the S. cerevisiae strain harboring all genes 
necessary for Reb M production except UGT76G1. 
Forty-six independent transformants were screened for 
each of the 38 selected sites along with two wild-type 
controls for each site, resulting in a total of 1824 clones. 
Using NNS-degenerate primers, a theoretical codon cov-
erage of 85% was achieved resulting in an average of 17 
different amino acids being represented per position [37]. 
Reb D and Reb M production was measured in S. cerevi-
siae cultures from all the clones expressing the UGT76G1 
variants. Within the 76 S. cerevisiae clones expressing 
wild-type UGT76G1, the accumulation of Reb D and Reb 
M showed variation in the accumulation level of Reb D 
between 0.18 and 12.17 µM and variation in the Reb M 
levels between 0.4 and 43 µM, whereas the ratio between 
the two rebaudiosides was constant with a Reb D/Reb M 
ratio of 0.25 ± 0.02 (Additional file 2: Figure S2).
Analysis of the 38 residues that were site-saturated 
(Fig.  5) showed that mutagenesis of 19 of the targeted 
residues exhibited a tendency for generating UGT76G1 
variants that increased the average Reb D/Reb M ratio 
as evaluated from the 46 clones screened for each site. 
Fig. 4 RMSD between the tertiary structure of UGT76G1 and the four crystal based structural templates. Blue <1 Å; Green 1–2 Å; Yellow 2–3 Å; 
Orange 3–4 Å and Red >4 Å. Numbering is according to the UGT76G1 amino acid sequence. S UGT76G1 residues selected for site-saturation 
mutagenesis. C residues considered for site-saturation mutagenesis but found to be fully conserved
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In contrast, analysis of the clones from the target sites 
Leu85, His155 and Leu379 predominantly gave rise to 
UGT76G1 variants with a decreased Reb D/Reb M ratio. 
The ratio between the two rebaudiosides produced was 
characterized as being different from the wild-type ratio 
if it was more than two standard deviations above or 
below.
The 47 S. cerevisiae clones that produced more than 
23 µM Reb D and the 47 clones that produced more than 
34 µM Reb M (Additional file 2: Figure S2) were re-tested 
in triplicate. Of these, the 30 clones that showed the high-
est accumulation of Reb D (Fig. 6a, b) and the 18 clones 
that showed highest accumulation of Reb M (Fig. 6c, d) 
were sequenced and selected for further study. These 
clones were defined as High Reb D mutants and High Reb 
M mutants, respectively. Rubusoside, Reb B, A, D and M 
were quantified based on authentic standards, whereas 
the amounts of 13- and 19-SMG, 1,2- and 1,3-bioside, 
1,2-stevioside and Reb G, E and Q present were assessed 
from the LC–MS profiles and the AUC units recorded for 
each of the compounds.
A total of thirty-three unique UGT76G1 variants were 
identified among the 30 high Reb D variants and 18 high 
Reb M variants investigated. Unexpectedly, a Ser389Phe 
mutation, which was not at a residue selected for site-sat-
uration mutagenesis appeared together with a Leu257Arg 
substitution in a high Reb D variant.
Analysis of the S. cerevisiae strains selected for 
increased Reb D accumulation showed up to four times 
the content of Reb D by increasing the concentration 
from 5 µM in the strain expressing wild-type UGT76G1 
to above 18 µM in several of the strains containing site-
saturated UGT76G1 variants (Fig.  6a). In the same 
strains, the accumulation of Reb M was reduced from 
23  µM in the strain expressing wild-type UGT76G1 
to 2  µM in strains expressing UGT76G1Thr146Gly and 
UGT76G1Ser283Asn. Accumulation of 1,2-stevioside and 
Reb E increased from AUC-levels 130 × 103 to 681 × 103 
and 49 × 103 to 541 × 103, respectively, between strains 
expressing wild-type UGT76G1 and a strain that does 
not express UGT76G1. The 1,2-stevioside and Reb E 
are both known substrates for UGT76G1 and the high 
Reb D mutants showed elevated levels of these two ste-
viosides. Other UGT76G1 substrates such as 13-SMG, 
rubusoside and Reb A did not accumulate in increased 
concentrations in any of the mutants tested. Likewise, the 
unwanted side-products 1,3-bioside, Reb G and Reb Q 
did not increase (Fig. 6b, d).
Analysis of the S. cerevisiae clones selected for 
increased Reb M accumulation identified five UGT76G1 
mutations (Thr55Lys, His155Leu, Thr284Gly, Lys337Glu 
and Lys337Pro) that offered increased production of Reb 
M. The increase in production was significant but not 
nearly as remarkable as observed for Reb D. The mutant 
clones all showed similar levels of 13-SMG, Reb A, Reb 
B and rubusoside accumulation compared to clones 
expressing wild-type UGT76G1. 19-SMG and 1,3-bio-
side were not detected in any of the samples while a gen-
eral increase in Reb D level was observed in the strains 
expressing high Reb M UGT76G1 variants (Fig. 6c, d).
Effect of site‑saturating the UGT76G1 binding pocket, 
as predicted by homology modelling
In this study, a high quality homology model of 
UGT76G1 was built based on four solved UGT crys-
tal structures and assessed to show a high likelihood of 
Fig. 5 Effect of site-saturating selected amino acid residues the UGT76G1 binding pocket on activity and Reb D and Reb M accumulation. 46 colo-
nies containing UGT76G1 variants were screened for each of the selected 38 different amino acid positions compared to colonies expressing the 
wild-type enzyme. The N and C in parenthesis next to a residue denotes whether the residue resides in the N- or C-terminal domain of UGT76G1
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correct folding. Docking of Reb D and Reb M into the 
active site of UGT76G1 identified 38 non-conserved 
amino acid residues within a distance of less than 5  Å 
from the bound steviol glucosides. Of these, 28 residues 
were situated within the N-terminal part of UGT76G1 
while only 10 resided in the C-terminal domain. This is 
in agreement with earlier observations indicating that the 
N-terminal domain is primarily responsible for sugar-
acceptor interactions whereas the PSPG- motif in the 
C-terminal binds the activated sugar-donor [38–40].
Out of the 38 residues that were subjected to site-sat-
uration mutagenesis, Gly24, Trp127 and Asp380 showed 
the highest sensitivity to mutagenesis with 52, 61 and 
91% of the tested yeast clones showing no UGT76G1 
activity, respectively, indicating that these residues are 
important for the catalytic function (Fig.  5). Of these 
three, Gly24 is positioned next to the catalytic His25 and 
the substitution of the small side-chain of glycine with 
a bulky or positive charged side-chain could interfere 
with the stabilizing interaction of Asp124 and His25. The 
importance of the Gly24 residue was also apparent from 
the crystal structures used as templates for the homol-
ogy model, where only glycine or threonines were found 
at this position. Trp127 forms a π-stack with Phe18 
(Fig. 7a) stabilizing the N-terminal domain of UGT76G1, 
while Asp380 is part of the glycosyltransferase PSPG-
motif. Asp380 was included in the screen because it was 
not 100% conserved with VvGT1, the exception hav-
ing a glutamate at this position. That 91% of the Asp380 
mutated clones had no activity (Fig.  5) indicates that a 
negative charge at this position is critical for activity. In 
the homology model of UGT76G1, the carboxylic acid of 
Asp380 interacts by hydrogen bonding to the side-chains 
of Asn151, Lys191, Asn384 and to a glucose residue of 
Reb M. Asp380, Asn151, and Lys191 form a triad that 
stabilizes that region of the UGT (Fig. 7b). It is therefore 
not surprising that mutating Asp380 disrupted the stabil-
ity of UGT76G1 and gave rise to a high number of clones 
with no activity. Although part of the triad, the residues 
between Lys191 and Glu202 were less susceptible to loss 
Fig. 6 LC-MS analysis of the steviol glucosides present in the S. cerevisiae clones expressing UGT76G1 variants. a, b UGT76G1 variants found to 
increase Reb D accumulation (High Reb D variants); c, d UGT76G1 variants examined for increased Reb M accumulation (High Reb M variants). The 
number of clones identified to harbour the same UGT76G1 mutation is shown. For the three variants Thr146Pro, Leu257Arg and Thr55Lys, no error 
bars are shown because only a single sample of each was screened due to background strain variation during transformation. Two sets of wild-type 
controls (WT) were analysed in triplicate with each test. Steviol, steviol-19-O-glucoside (19-SMG) and 1,3-bioside were not detected in any of the 
samples. The steviol glucosides in a and c were quantified based on authentic reference compounds whereas those in b and d were assessed by 
their respective AUC units (area under curve)
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of enzyme function as more than 50% of the clones dis-
played wild-type ratios of Reb D and Reb M accumula-
tion (Fig. 5).
In the primary screen, it was found that the SSL’s for the 
three positions: Leu85, His155, and Leu379 resulted in 
several UGT76G1 colonies with increased Reb M/Reb D 
ratio. None of the Leu85 colonies was selected for further 
study due to insufficient accumulation of Reb M, while 
three colonies from the His155 and one colony from 
the Leu379 SSL were selected for increased Reb M/Reb 
D ratio. His155 forms a hydrogen bond to the 1,2-glu-
cose attached to the C13-position of the steviol backbone 
while the di-methyl group on Leu379 maintains the three 
glucose moieties in a planar conformation and interacts 
with the steviol C16-methylene group (Fig.  7c). In those 
UGT76G1 variants where increased production of Reb 
M was observed, these interactions would appear to have 
been favoring Reb D to Reb M conversion.
Yeast expressing UGT76G1 variants with the muta-
tions Lys337Pro, and the single successful replicate of 
Thr55Lys, showed an increase in Reb M accumulation 
of approximately 20% when compared to the wild-type 
(Fig.  6c). The side-products generated by glucosyla-
tion of rubusoside to Reb G and Reb Q in these mutants 
were almost abolished with no Reb G detected and one-
third of the Reb Q levels present in strains expressing 
UGT76G1Lys337Pro compared to wild-type UGT76G1. 
Thr55 and Lys337 are positioned at the entrance of the 
binding site and could regulate the binding and the dis-
sociation of the sugar-acceptor ligands. Furthermore the 
hydroxyl side chain of Thr55 forms a hydrogen-bond with 
the 1,3-glucose bound to the C19 attached glucose on the 
steviol backbone. The Thr55Lys substitution eliminates 
formation of a hydrogen-bond to Reb M. The hydrocar-
bon chain of Lys337 interacts with the hydrophobic side-
chain of Leu257. Changing Lys337 into a proline could 
help stabilize the hydrophobic interaction. UGT76G1Th-
r284Gly gave increased accumulation of all steviol gluco-
sides except rubusoside and the side-products Reb G and 
Reb Q.
High Reb D mutants were found to primarily arise 
as a result of the reduced ability of UGT76G1 to cata-
lyze the Reb D to Reb M reaction. Other reactions were 
also inhibited as evident by increased accumulation of 
the UGT76G1 substrates 1,2-stevioside and Reb E, with 
1,2-stevioside AUC increasing up to four times that of 
the clones expressing wild-type UGT76G1, while Reb 
E AUC increased up to seven times (Fig. 6b). The addi-
tional accumulation of Reb D observed in the high Reb 
M mutants may reflect inhibition of the sequential 
UGT76G1 catalyzed side-reactions from rubusoside to 
Reb G and Reb Q, and the reduced Reb B accumulation 
Fig. 7 Residue interactions as predicted by UGT76G1 homology modelling. a π-stacking between Phe18 and Trp127 b Hydrogen bond forma-
tion from Asp380 to Asn151, Lys191, Asn384 and to a Reb M glucose moiety. c Hydrogen bond formation from His155 with Reb M and the Leu379 
directing planar conformation of the glucose residues of the stevioside. d Hydrogen formation from Ser283 to the C13-glucose moieties
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in the cells (Fig.  1). The UGT76G1 variants Ile26Trp 
and Ser283Gly showed the highest Reb D/1,2-stevioside 
ratio, indicating that these mutations have low activity 
on Reb D without mitigating the 1,2-stevioside to Reb 
A reaction. Docking Reb D into the UGT76G1’s binding 
pocket showed that the hydroxyl group of Ser283 inter-
acts in hydrogen bond formation with the C13-glucose 
moiety as well as to the ring-oxygen of the 1,3-bound 
glucose (Fig. 7d). The Ser283Gly mutation removed these 
hydrogen-bonds, which could reduce the binding affin-
ity of Reb D. The 1,2-stevioside does not possess a 1,3-
bound glucose moiety attached to the 13-O-glucose and 
the reduction in binding affinity would not be as pro-
nounced with this substrate. Ile26 is part of the hydro-
phobic core of the N-terminal domain, but the side-chain 
is not directly interacting with the ligands indicating that 
the effect of the mutation is due to changes in structural 
flexibility or stability.
The UGT76G1 variant Leu257Gly was identified six 
times and gave rise to almost four times as high accumu-
lation of Reb D compared to wild-type UGT76G1. The 
UGT76G1 variants resulting in the highest Reb D/Reb 
M ratio were Thr146Gly and Ser283Asn. These variants 
had a Reb D/Reb M ratio that was up to 50 times higher 
compared to the wild-type UGT76G1, from a Reb D/Reb 
M ratio of 0.25 in the wild-type to almost 12 in UGT76G-
1Ser283Asn. Thr146 is engaged in hydrogen-bond forma-
tion to the catalytic His25 while Leu257 is part of a highly 
flexible outer loop that only interacts with Reb M. The 
Ser283Asn variant reduces the conversion of Reb D to 
Reb M. The decreased activity could be due to reduction 
in the binding pocket size, restricting access to Reb D.
The Ser389Phe mutation identified together with 
Leu257Arg gave a higher Reb D accumulation than 
Leu257Arg alone, despite its position on the enzyme 
surface away from the ligand binding site and Leu257. 
These results open up for generation of double mutants 
to investigate their effect on the Reb D/Reb M ratio, con-
tra the general catalytic activity of UGT76G1. Despite 
the increase in Reb D observed for the Reb D variants, a 
large pool of precursor glucosides was also observed with 
these variants. This pool of precursors could potentially 
be better utilized if the Reb D mutations were combined 
with one of the catalytically more active Reb M muta-
tions, further increasing the accumulation of Reb D.
Discussion
The in  vitro investigation of wildtype UGT76G1 dem-
onstrated that this enzyme has a broad substrate speci-
ficity catalyzing glucosylation of numerous steviol 
glucosides in addition to Reb D and Reb M (Fig. 1). This 
was expected since UGTs are known to be promiscuous, 
catalyzing glucosylation reaction on classes of substrates, 
rather than single molecules [35, 41]. In this case, these 
additional reactions can give rise to the side-products 
1,3-bioside, 1,3-stevioside (Reb G), Reb Q and Reb I, none 
of which could be converted to Reb D or Reb M by the 
tested UGT. Hence engineering the substrate specificity 
of UGT76G1 is imperative for obtaining variants that can 
be used to improve Reb D and Reb M production.
The key to engineering the substrate specificity of 
enzymes is the ability to identify the residues involved in 
substrate selectivity from the vast array of amino acids 
substitution and their possible combinations within a 
single protein. Residue identification has traditionally 
been done through the analysis of crystal structures as 
e.g. done by He et al. [42], who found that it was possible 
to change the regio-selectivity of UGT71G1 on querce-
tin and obtain activity towards genistein by site directed 
mutagenesis of key residues, such as UGT71G1Phe148Val 
and UGT71G1Tyr202Ala in the binding pocket [42].
However, when crystal structures are not available, 
previous studies had to rely on random mutagenesis in 
combination with effective high-throughput screens or 
selection schemes. Nonetheless, in some cases neither 
a crystal structure of the target protein is available, nor 
is it possible to identify a selection pressure for a high-
throughput screening method. To remedy this and allow 
for optimization of such proteins the search space would 
have to be reduced so the number of samples to be ana-
lyzed can more readily be handled. A way to achieve this 
has been through the advent of homology modelling.
Homology modelling of UGT76G1 was based on plant 
UGT crystal structures [28–31] which enabled predic-
tions of the residues located in the binding pocket of the 
UGT.
When the UGT71G1 crystal structure and UGT76G1 
homology model is superimposed, Phe148 and Tyr202 
from UGT71G1 are found to be structurally close to 
Asn151, His155 and Ile203 UGT76G1 SSL’s. Although 
no colonies were selected for further studies for the 
Asn151 and Ile203 SSL, these positions were found 
to yield 70–80% colonies with a change in specificity 
towards Reb D, while the UGT76G1His155 SSL changed 
specificity towards Reb M (Fig. 5) indicating the impor-
tance of these positions in UGT’s for substrate selectivity. 
Despite the high degree of secondary structural homol-
ogy between UGTs [34], it is not currently possible to 
reliably predict the exact orientation and interactions 
of the UGT76G1 residue side-chains with the ligands 
due to (1): the diversity and flexibility of the N-terminal 
sugar-acceptor domains in UGTs and (2): that there are 
currently no crystal structures of UGTs with steviol glu-
cosides co-crystallized in the binding pocket, this prob-
lem was observed with UGT94B1 [39], where homology 
modelling made it possible to change the sugar-donor 
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specificity of UGT94B1 from UDP-glucuronic acid to 
UDPG by site-directed mutagenesis, but was unable 
to change the sugar acceptor specificity from cyanidin 
3-O-glucoside to delphinidin 3-O-glucoside by point 
mutations in the acceptor binding pocket, despite chang-
ing residues seen to be involved in specificity such as 
Asn123 corresponding to the Leu126 SSL in UGT76G1 
and Ile187 corresponding to Tyr202 in UGT71G1 and 
the Ile203 SSL in UGT76G1 as described above. There-
fore changing UGT76G1 sugar acceptor substrate speci-
ficity to improve Reb D and Reb M accumulation while 
simultaneously reducing side-product reactions neces-
sitated a directed evolution approach. Early attempts at 
altering the glycosyltransferase substrate specificity relied 
on error prone PCR (epPCR) due to the lack of structural 
knowledge of the enzyme at the given time, and high 
throughput screening using an fluorescent aglycone to 
enable directed evolution of the sugar donor specificity 
[43]. The residues identified in this screen was then used 
to continue the directed evolution towards a non-fluores-
cent aglycone by performing site-saturation mutagenesis 
on three residues relying on LC–MS for analysis [44]. 
Here site-saturation mutagenesis was selected for the 
directed evolution of UGT76G1, since it decreases sam-
ple space by function of its controlled ratio of nucleotides 
at each given position of a codon, giving a better coverage 
of the mutation space for each amino acid investigated. 
Furthermore, site-saturation mutagenesis can be tar-
geted to specific regions of the enzyme such as the bind-
ing pocket to further reduce sample space as enabled by 
homology modelling.
Further reduction of the library size was achieved 
using multiple sequence alignment to omit 11 residues 
found to be fully conserved, such as the catalytic His-Asp 
dyad and a number of residues part of the PSPG-motif, 
as these were assumed to primarily yield loss of func-
tion variants. This was also what was found by He et al. 
[42], who got inactive variants when mutating Trp339, 
His357, Trp360, Asn361 and Gln382 in the UGT71G1 
PSPG motif, corresponding to residues that was omit-
ted from the UGT76G1 screen due to full conservation 
of the residues [42] The importance of these residues is 
also seen in this study, by the loss of activity in 91% of the 
UGT76G1variants located at Asp380 which is part of the 
PSPG-motif.
By screening 46 colonies for each of the 38 site-sat-
uration libraries, it was possible to gain an 85 and 98% 
chance of identifying the most, or one of top two, most 
beneficial mutations respectively, for each of the 38 resi-
dues mutagenized in the binding pocket ensuring opti-
mal geometry and amino acid properties for Reb D and 
Reb M production [37]. Without homology modelling 
support, attaining the same coverage for each of the 
456 residues of UGT76G1, would have required screen-
ing 20,976 variants. In the absence of a crystal structure, 
homology modelling assisted site-saturation mutagenesis 
of UGT is the most thorough method for modulating 
substrate specificities currently available, whilst simul-
taneously ensuring a minimum amount of screening 
redundancy.
While general purpose, high throughput screening 
methods are becoming available for glycosyltransferases, 
none of the current methods were applicable for this 
study, either because the established screening methods 
rely on fluorescent substrate analogs which are not suit-
able for substrate specificity screens [45–47], pH changes 
which would be indistinguishable from the yeast endog-
enous metabolism [48], or detection of uridine diphos-
phate (UDP) produced as a function of UGT activity 
which would cause background noise due to the UDP 
found in yeast cells [49–52]. Furthermore, none of these 
assays would be able to differentiate between the two 
sequential reactions UGT76G1 is capable of performing 
on rubusoside, stevioside and reb E. Beside this, investi-
gating 1748 variants for eight different reactions with an 
in vitro screen would be significantly more laborious than 
LC–MS analysis. Instead of investigating the variants on 
individual substrates, performing the UGT76G1 directed 
evolution in  vivo using a yeast rebaudioside-production 
strain as platform, made it possible to screen for all reac-
tions simultaneously by LC–MS analysis. While screen-
ing 1748 samples by LC–MS are manageable, ensuring a 
minimum of sample redundancy is still paramount.
Conclusions
UGT76G1 is a chameleon enzyme catalyzing at least 
eight different glucosylation steps in the metabolic gly-
cosylation grid of steviol glycosides. Several of the 
UGT76G1 catalyzed steps result in formation of unde-
sired steviol glucosides (1,3-bioside, Reb G, Reb Q and 
Reb I), none of which can be converted to the premium 
steviol glucosides Reb D and Reb M (Fig. 1) [7].
Here we demonstrate how homology models of a highly 
promiscuous UGT can be used in combination with semi 
high-throughput analytic methods to effectively probe 
the immense sequence search space. This allowed for 
the identification and subsequent characterization of key 
residues involved in UGT specificity yielding variants, 
such as UGT76G1Thr146Gly and UGT76G1His155Leu, which 
results in S. cerevisiae strains with increased or specific 
production of Reb D and Reb M. This demonstrated that 
site-saturation mutagenesis targeting the binding pocket 
of UGT76G1 constitutes an important tool that allows 
for tailored production of Reb D and Reb M. This can be 
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used to achieve steviol glucoside products with low sweet 
threshold values and increased sweetness intensity.
This study is to our knowledge the most comprehensive 
analysis of the substrate specificity of a UGT published 
to date, and shows how homology modelling in combi-
nation with a yeast production strain and LC–MS make 
it possible to engineer a highly promiscuous enzyme 
towards enabling next generation stevia sweeteners.
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Additional file 1: Figure S1. Product formation following incubation of 
S. cerevisiae lysate containing UGT76G1 with 1,2-stevioside or Reb A and 
UDPG. A novel steviol glucoside with an m/z value corresponding to ste-
viol attached to 5 glucose moieties (m/z = 1151.150–1151.650) appeared 
at retention time 1.97 min which partially co-elutes with 1,2-stevioside 
and rebaudioside A fragment ions at 2.05–2.08 min. Based on the 1,3-glu-
cosylation reactions catalyzed by UGT76G1, the compound is expected to 
be rebaudioside I [12]. NL: Noise Level.
Additional file 2: Figure S2. Reb D and Reb M accumulation in S. 
cerevisiae strains transformed with the UGT76G1 site-saturation library. The 
shaded area indicates the Reb D/M ratio for the wild-type controls, while 
the dashed boxes indicate which colonies were selected for retest and 
sequencing of the expressed site-saturation UGT76G1 variants.
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